West Pharmaceutical Services, Inc. $WST Shares Sold by Atria Wealth Solutions Inc.

Atria Wealth Solutions Inc. trimmed its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 72.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,123 shares of the medical instruments supplier’s stock after selling 2,898 shares during the period. Atria Wealth Solutions Inc.’s holdings in West Pharmaceutical Services were worth $246,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Zions Bancorporation National Association UT acquired a new position in shares of West Pharmaceutical Services in the 1st quarter valued at $25,000. Quarry LP acquired a new position in shares of West Pharmaceutical Services in the 1st quarter valued at $27,000. First Horizon Advisors Inc. lifted its stake in shares of West Pharmaceutical Services by 85.0% in the 1st quarter. First Horizon Advisors Inc. now owns 185 shares of the medical instruments supplier’s stock valued at $41,000 after purchasing an additional 85 shares during the period. Cromwell Holdings LLC lifted its stake in shares of West Pharmaceutical Services by 587.5% in the 2nd quarter. Cromwell Holdings LLC now owns 220 shares of the medical instruments supplier’s stock valued at $48,000 after purchasing an additional 188 shares during the period. Finally, Brooklyn Investment Group lifted its stake in shares of West Pharmaceutical Services by 83.3% in the 1st quarter. Brooklyn Investment Group now owns 275 shares of the medical instruments supplier’s stock valued at $61,000 after purchasing an additional 125 shares during the period. 93.90% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the stock. Evercore ISI set a $350.00 target price on shares of West Pharmaceutical Services in a research note on Tuesday, October 7th. Weiss Ratings reiterated a “hold (c)” rating on shares of West Pharmaceutical Services in a research note on Tuesday, October 14th. Wall Street Zen upgraded shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating in a research note on Saturday, July 26th. Rothschild Redb upgraded shares of West Pharmaceutical Services to a “strong-buy” rating in a research note on Monday, September 15th. Finally, Redburn Partners set a $311.00 price objective on shares of West Pharmaceutical Services in a research report on Monday, September 15th. Two analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $321.89.

West Pharmaceutical Services Stock Performance

WST opened at $276.87 on Thursday. The company has a quick ratio of 2.08, a current ratio of 2.78 and a debt-to-equity ratio of 0.07. The company has a market cap of $19.91 billion, a price-to-earnings ratio of 41.45, a PEG ratio of 4.90 and a beta of 1.07. West Pharmaceutical Services, Inc. has a 52-week low of $187.43 and a 52-week high of $352.33. The firm’s fifty day simple moving average is $257.04 and its two-hundred day simple moving average is $232.65.

West Pharmaceutical Services (NYSE:WST) last posted its quarterly earnings data on Thursday, July 24th. The medical instruments supplier reported $1.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.51 by $0.33. The business had revenue of $766.50 million for the quarter, compared to the consensus estimate of $725.11 million. West Pharmaceutical Services had a net margin of 16.48% and a return on equity of 18.43%. The company’s revenue was up 9.2% compared to the same quarter last year. During the same period last year, the firm posted $1.52 earnings per share. Equities analysts anticipate that West Pharmaceutical Services, Inc. will post 6.62 earnings per share for the current fiscal year.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.